ACER
Acer Therapeutics Inc

10,117
Mkt Cap
$16.15M
Volume
574,675.00
52W High
$4.56
52W Low
$0.5515
PE Ratio
-0.34
ACER Fundamentals
Price
$0.6601
Prev Close
$0.8045
Open
$0.7968
50D MA
$0.8149
Beta
1.03
Avg. Volume
83,170.00
P/B
-0.49
Loading...
Loading...
Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Acer Therapeutics Inc?
What is the 52-week high for Acer Therapeutics Inc?
What is the 52-week low for Acer Therapeutics Inc?
What is Acer Therapeutics Inc stock price today?
What was Acer Therapeutics Inc stock price yesterday?
What is the PE ratio of Acer Therapeutics Inc?
What is the Price-to-Book ratio of Acer Therapeutics Inc?
What is the 50-day moving average of Acer Therapeutics Inc?

Latest ACER News

View
No ACER news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.